Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 310

1.

Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells.

Rhodes LV, Bratton MR, Zhu Y, Tilghman SL, Muir SE, Salvo VA, Tate CR, Elliott S, Nephew KP, Collins-Burow BM, Burow ME.

Exp Cell Res. 2011 Nov 1;317(18):2573-81. doi: 10.1016/j.yexcr.2011.08.016. Epub 2011 Aug 30.

2.

Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk.

Rhodes LV, Antoon JW, Muir SE, Elliott S, Beckman BS, Burow ME.

Mol Cancer. 2010 Nov 18;9:295. doi: 10.1186/1476-4598-9-295.

3.

Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.

Sauvé K, Lepage J, Sanchez M, Heveker N, Tremblay A.

Cancer Res. 2009 Jul 15;69(14):5793-800. doi: 10.1158/0008-5472.CAN-08-4924. Epub 2009 Jul 7.

4.

Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer.

Rhodes LV, Short SP, Neel NF, Salvo VA, Zhu Y, Elliott S, Wei Y, Yu D, Sun M, Muir SE, Fonseca JP, Bratton MR, Segar C, Tilghman SL, Sobolik-Delmaire T, Horton LW, Zaja-Milatovic S, Collins-Burow BM, Wadsworth S, Beckman BS, Wood CE, Fuqua SA, Nephew KP, Dent P, Worthylake RA, Curiel TJ, Hung MC, Richmond A, Burow ME.

Cancer Res. 2011 Jan 15;71(2):603-13. doi: 10.1158/0008-5472.CAN-10-3185. Epub 2010 Dec 1. Erratum in: Cancer Res. 2011 May 1;71(9):3432.

5.

ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer.

Appaiah H, Bhat-Nakshatri P, Mehta R, Thorat M, Badve S, Nakshatri H.

Cancer Biol Ther. 2010 Sep 15;10(6):600-14. Epub 2010 Sep 4.

7.

Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancer.

Weekes CD, Song D, Arcaroli J, Wilson LA, Rubio-Viqueira B, Cusatis G, Garrett-Mayer E, Messersmith WA, Winn RA, Hidalgo M.

Neoplasia. 2012 Aug;14(8):690-701.

8.

The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells.

Yoshida D, Koketshu K, Nomura R, Teramoto A.

J Neurooncol. 2010 Oct;100(1):51-64. doi: 10.1007/s11060-010-0152-6. Epub 2010 Mar 23.

PMID:
20309720
9.

Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis.

Bi X, Hameed M, Mirani N, Pimenta EM, Anari J, Barnes BJ.

Breast Cancer Res. 2011;13(6):R111. doi: 10.1186/bcr3053. Epub 2011 Nov 4.

10.
11.

Inhibition of SDF-1/CXCR4-induced epithelial-mesenchymal transition by kisspeptin-10.

Gründker C, Bauerschmitz G, Knapp J, Schmidt E, Olbrich T, Emons G.

Breast Cancer Res Treat. 2015 Jul;152(1):41-50. doi: 10.1007/s10549-015-3463-7. Epub 2015 Jun 11.

PMID:
26062751
12.

The SDF-1α/CXCR4 axis is required for proliferation and maturation of human fetal pancreatic endocrine progenitor cells.

Kayali AG, Lopez AD, Hao E, Hinton A, Hayek A, King CC.

PLoS One. 2012;7(6):e38721. doi: 10.1371/journal.pone.0038721. Epub 2012 Jun 22.

13.

Quantitative phosphoproteomic analysis reveals system-wide signaling pathways downstream of SDF-1/CXCR4 in breast cancer stem cells.

Yi T, Zhai B, Yu Y, Kiyotsugu Y, Raschle T, Etzkorn M, Seo HC, Nagiec M, Luna RE, Reinherz EL, Blenis J, Gygi SP, Wagner G.

Proc Natl Acad Sci U S A. 2014 May 27;111(21):E2182-90. doi: 10.1073/pnas.1404943111. Epub 2014 Apr 29. Erratum in: Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):11223.

15.

MEK5/ERK5 signaling suppresses estrogen receptor expression and promotes hormone-independent tumorigenesis.

Antoon JW, Martin EC, Lai R, Salvo VA, Tang Y, Nitzchke AM, Elliott S, Nam SY, Xiong W, Rhodes LV, Collins-Burow B, David O, Wang G, Shan B, Beckman BS, Nephew KP, Burow ME.

PLoS One. 2013 Aug 9;8(8):e69291. doi: 10.1371/journal.pone.0069291. eCollection 2013.

16.

Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.

Kobayashi T, Tsuda H, Moriya T, Yamasaki T, Kikuchi R, Ueda S, Omata J, Yamamoto J, Matsubara O.

Breast Cancer Res Treat. 2010 Oct;123(3):733-45. doi: 10.1007/s10549-009-0672-y. Epub 2009 Dec 18.

PMID:
20020198
17.

IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis.

Panneerselvam J, Jin J, Shanker M, Lauderdale J, Bates J, Wang Q, Zhao YD, Archibald SJ, Hubin TJ, Ramesh R.

PLoS One. 2015 Mar 16;10(3):e0122439. doi: 10.1371/journal.pone.0122439. eCollection 2015.

18.

CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma.

Zhao BC, Wang ZJ, Mao WZ, Ma HC, Han JG, Zhao B, Xu HM.

World J Gastroenterol. 2011 May 21;17(19):2389-96. doi: 10.3748/wjg.v17.i19.2389.

19.

Effects of the chemokine CXCL12 and combined internalization of its receptors CXCR4 and CXCR7 in human MCF-7 breast cancer cells.

Hattermann K, Holzenburg E, Hans F, Lucius R, Held-Feindt J, Mentlein R.

Cell Tissue Res. 2014 Jul;357(1):253-66. doi: 10.1007/s00441-014-1823-y. Epub 2014 Apr 26.

20.

Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4.

Cronin PA, Wang JH, Redmond HP.

BMC Cancer. 2010 May 21;10:225. doi: 10.1186/1471-2407-10-225.

Items per page

Supplemental Content

Write to the Help Desk